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Rochester, Minnesota
Objectives Our goal was to investigate whether left ventricular (LV) diastolic dysfunction was an important pathophysiologi-
cal mechanism underlying the initiation of new-onset post-operative atrial fibrillation (POAF).
Background Atrial fibrillation is a common complication after cardiac surgery. However, the precise mechanism underlying its
development remains poorly understood. Pre-existing alterations of myocardial diastolic function may predis-
pose patients to the development of POAF.
Methods Patients were residents of Olmsted County, Minnesota, who underwent complete LV diastolic function assess-
ment before coronary artery bypass grafting and/or valve surgery between January 1, 2000, and December 31,
2005. All were in sinus rhythm and had no history of atrial fibrillation, a pacemaker, mitral stenosis, or congeni-
tal heart disease. POAF was defined as any episode of atrial fibrillation within 30 days after surgery.
Results POAF occurred in 135 of 351 patients (38.5%). Patients with POAF were older (mean age 72.5  10.3 years vs.
63.1  14.1 years; p  0.001) and more likely to have abnormal diastolic function. The rate of POAF increased
exponentially with diastolic function grade (DFG) severity (p  0.001). By multivariate analysis, after adjusting
for clinical and surgical risk factors, independent predictors of POAF were older age (odds ratio [OR]: 1.05; p 
0.001), higher body mass index (OR: 1.06; p  0.03), and abnormal LV DFG (DFG 1, OR: 5.12 [p  0.006]; DFG
2, OR: 9.87 [p  0.001]; and DFG 3, OR: 28.52 [p  0.001]).
Conclusions LV diastolic dysfunction is a powerful, independent predisposing substrate for the initiation of POAF. Evaluation
may be useful during risk stratification of patients undergoing cardiac surgery. (J Am Coll Cardiol 2011;58:
953–61) © 2011 by the American College of Cardiology Foundation
Published by Elsevier Inc. doi:10.1016/j.jacc.2011.05.021Atrial fibrillation (AF) occurs in a substantial subset of
patients after cardiac surgery. It has been ascribed to various
clinical risk factors closely linked to alterations of myocar-
dial diastolic properties, including advanced age, hyperten-
sion, left ventricular (LV) hypertrophy, obesity, metabolic
syndrome, LV dysfunction, and left atrial enlargement
(1–5). New-onset post-operative atrial fibrillation (POAF)
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accepted May 10, 2011.is a major cause of morbidity and mortality. It is associated
with increased risk of stroke and death and constitutes a
substantial use of healthcare resources, including increased
duration of hospitalization and hospital costs (1,4,6–8).
Despite the documented clinical impact of POAF, there
are no uniformly accepted treatments for its prevention, in
part due to a lack of mechanistic understanding. Previous
studies have focused on the determinants of POAF, but
most factors are not modifiable, nor have researchers pro-
vided a clear physiological basis for pre-operative risk
stratification or potential prophylactic treatment (1,4,9).
Age, which is often associated with abnormal myocardial
relaxation due to alterations in ventricular compliance (10–12),
is the only risk factor most consistently identified as a major
independent predictor for the development of POAF
(1,3,9). The pathophysiological mechanisms of POAF
therefore may be linked to pre-existing, age-related, and
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tional changes in the atrial and
ventricular myocardium; these
changes may contribute to the de-
velopment of a proarrhythmic sub-
strate that subsequently promotes
the development of POAF. In this
study, we sought to assess the hy-
pothesis that impaired LV compli-
ance is a principal culprit for the
changing hemodynamic properties
of the left atrium, predisposing
patients to atrial arrhythmogenesis
after cardiac surgery.
Methods
Study patients. The study was approved by the Mayo
Clinic Institutional Review Board, and all patients gave
written informed consent for participation in the study. It
was conducted in Olmsted County, Minnesota, where
comprehensive healthcare records with high-quality infor-
mation have been maintained. Records covered all health-
care encounters and included clinical reports, echocardio-
graphic reports, laboratory test results, pathology reports,
and autopsy results. Complete medical records from con-
secutive Olmsted County patients were prospectively en-
tered into a clinical database and retrospectively reviewed to
investigate the relationship between diastolic dysfunction
severity and the risk of developing new-onset POAF.
For the present investigation, eligible patients were resi-
dents of Olmsted County and could be of any age. The age
of the study population was 66.7  13.6 years, and 236
patients (67.2%) were men. All had pre-operative sinus
rhythm and underwent isolated coronary artery bypass graft
(CABG) and/or valvular repair or replacement (or some
combination thereof), and survived the operation (n 752).
Our cohort did not include patients with congenital heart
disease. We excluded patients with a pre-operative history
of AF (n  71), pacemaker (n  37), Cox’s maze or
radiofrequency ablation procedure for atrial arrhythmias
(n  8), moderate or severe mitral stenosis (n  16), and
incomplete diastolic function assessment (n  269). Stan-
dard care for these patients involved coordinated treatment
between cardiologists and cardiac surgeons. All patients
included in the study (n  351) were Olmsted County
residents, which facilitated prospective follow-up.
Echocardiographic data. All patients underwent a pre-
operative, comprehensive transthoracic, 2-dimensional and
Doppler echocardiographic evaluation with state-of-the-art
technology within 3 months before surgery (median 6 days;
interquartile range [IQR]: 1 to 25 days). All pre-operative
echocardiograms were independently reviewed by 2 experi-
enced echocardiographers in a blinded fashion. Disagree-
ments about the diastolic function grade between the 2
Abbreviations
and Acronyms
AF  atrial fibrillation
CABG  coronary artery
bypass graft
CI  confidence interval
DFG  diastolic function
grade
LV  left ventricular
OR  odds ratio
POAF  post-operative
atrial fibrillationindependent physician reviews were resolved either byconsensus or by arbitration by a third reviewer. Measure-
ments of study variables were performed according to
established methods (13–15). Diastolic parameters were
integrated to form a global diastolic function score (grades
0–3) (13–17).
• Grade 0: Normal LV filling pressure; mitral E/A ratio
of 0.75 to 1.5, mitral deceleration time 160 to 240 ms,
e’ 8, E/e’ 8, pulmonary venous systolic forward
flow velocity  diastolic, pulmonary venous atrial
reversal duration shorter than mitral A flow duration,
and left atrial volume index 34 ml/m2.
• Grade 1: Normal to mildly elevated LV filling pressure
or impaired LV relaxation; mitral E/A ratio of 0.75,
mitral deceleration time 240 ms, e’ 8, E/e’ 8,
pulmonary venous systolic forward flow velocity di-
astolic, pulmonary venous atrial reversal duration
shorter than mitral A flow duration, and left atrial
volume index 34 ml/m2.
• Grade 2: Moderately elevated LV filling pressure or
pseudonormal LV diastolic filling; mitral E/A 0.75
to 1.5 with a decrease of 0.5 with Valsalva
maneuver, mitral deceleration time 160 to 240 ms, e’
8, E/e’ 9 to 12, pulmonary venous systolic forward
flow velocity  diastolic, pulmonary venous atrial
reversal duration longer than mitral A flow duration
(by 30 ms), and left atrial volume index 34 ml/m2.
• Grade 3: Severely increased LV filling pressure or
restrictive LV diastolic filling; mitral E/A 1.5 with a
decrease of 0.5 (reversible) or 0.5 (fixed) with
Valsalva maneuver, mitral deceleration time 160 ms,
e’ 8, E/e’ 13, pulmonary venous systolic forward
flow velocity  diastolic, pulmonary venous atrial
reversal duration longer than mitral A flow duration
(by 30 ms), and left atrial volume index 34 ml/m2.
Electrocardiography. All patients were monitored for the
occurrence of POAF with continuous electrocardiographic
telemetry until the day of hospital dismissal. A standard,
12-lead electrocardiogram was recorded on the day of
dismissal for each patient. POAF was based on documen-
tation of AF episodes by continuous telemetry throughout
hospitalization or electrocardiogram during follow-up
within 30 days after cardiac surgery.
Angiography. Coronary angiography results were obtained
from clinical reports composed by experienced angiogra-
phers at the time of cardiac catheterization. The degree of
coronary artery stenosis was visually estimated as a percent-
age of the normal segment preceding the stenosis. Clinically
significant coronary stenoses were defined as70% narrow-
ing of the luminal diameter of 1 major epicardial arteries
or a 50% left main artery stenosis. Patients with left main
coronary artery stenosis were considered to have 2-vessel
disease if there was right coronary dominance and 3-vessel
disease if there was left dominance.
Clinical predictors. On the basis of previous reports
(1–5,8,9,18), the covariates analyzed included pre-operative
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August 23, 2011:953–61 Pathophysiological Mechanism of POAFechocardiographic data, angiographic data, patient demo-
graphic data, coexisting medical conditions, pre-operative
cardiac medication use, and surgical factors.
Follow-up and outcome assessment. Patient records were
reviewed to ascertain the presence or absence of POAF
within 30 days after surgery. The 30-day clinical follow-up
was obtained by review of medical records, mailed surveys,
and telephone interviews. Patients who underwent a repeat
operation within 30 days of their indexed cardiac surgical
procedure were censored at time of repeat surgery.
Statistical analysis. Data are presented as proportions (%)
for categorical variables and as mean  SD or median
IQR) when appropriate for continuous variables. For
kewed variables, the median (range) is reported. Univariate
ssociation of variables with the outcome of POAF within
0 days was assessed using multivariable logistic regression.
or each variable, the odds ratio (OR), 95% confidence
nterval (CI), and p value are provided.
Exploratory data analyses were conducted using univari-
te summaries to examine distributions of key variables.
ariables significantly associated with POAF after univariate
nalysis (p 0.05) and those that were established risk factors
ere entered in a multivariable logistic regression model to
dentify the independent predictors of POAF. The perfor-
ance of the risk model was determined by using C statistics,
quivalent to the area under the receiver operating character-
stic curve. A C statistic of 0.5 indicates that the model
redictions are no better than chance (i.e., equal numbers of
rue and false positives), 0.7 indicates acceptable predictive
bility, and 1 implies a model with perfect predictive ability.
Post-operative complications and length of hospitaliza-
ion were compared for patients with and without POAF
sing the chi-square test and Wilcoxon rank sum tests,
espectively. The p value of 0.05 was selected as the
hreshold of statistical significance. Statistical analyses were
erformed using SAS software version 9.1 (SAS Institute,
nc., Cary, North Carolina).
esults
aseline characteristics. Table 1 shows criteria for grada-
ion of diastolic function. The baseline characteristics of the
Doppler Criteria for Classification of Diastolic Function and EstimaTable 1 Doppler Criteria for Classification of Diastolic Function
Criteria
Grade 0
(Normal Diastolic Function) (Imp
Mitral inflow E/A 0.75–1.5, DT 160–240 ms E/A
Mitral inflow at peak Valsalva maneuver E/A0.5 E/A
Septal e’ 8 8
TDI of mitral annular motion E/e’8 E/e’
Pulmonary venous flow S D, ARdur Adur S D
LA volume 34 ml/m2 34
LV compliance Normal Norm
LV filling pressure Normal Norm
A  mitral A-wave velocity at atrial contraction; Adur  mitral A-wave duration; ARdur  pulmo
eceleration time; e’  velocity of mitral annulus early diastolic motion; E  peak mitral early filling velo
oppler imaging.atients are summarized in Table 2 (data are stratified
ccording to occurrence of new-onset POAF and show
espective univariate p values). Overall, patients with POAF
ere more likely to be older (OR: 1.06; 95% CI: 1.04 to
.08; p  0.001) and had baseline renal insufficiency (OR:
.02; 95% CI: 1.05 to 3.92; p  0.04) compared with those
ho did not have POAF. The extent of obstructive coronary
rtery disease and pre-operative use of beta-blockers, anti-
rrhythmic agents, calcium channel blockers, angiotensin-
onverting enzyme inhibitors, angiotensin-receptor block-
rs, statins, or diuretics did not differ significantly between
he 2 groups.
ncidence and clinical course of new-onset POAF. The
verall incidence of new-onset POAF was 38.5% (n  135)
nd peaked at a median of 2 days (range 0 to 28 days),
asting a median of 2 days (range 0.04 to 18 days). Sinus
hythm was restored in 99.3% of patients before hospital
ismissal. Thirty-seven patients (27.4%) spontaneously con-
erted to sinus rhythm while receiving rate-controlling
gents, 71 patients (52.6%) received class III antiarrhythmic
edications, 5 patients (3.7%) underwent electrical cardio-
ersion, and 21 patients (15.6%) were treated with both
orms of cardioversion. The last patient who developed AF
days after hospital dismissal was managed with rate
ontrol and anticoagulation and remained in persistent AF
t 30-day follow-up.
Surgical data are presented in Table 3. Isolated CABG
urgery was performed in 160 patients (45.6%), aortic valve
urgery in 128 (36.5%), mitral valve surgery in 70 (19.9%),
ricuspid valve surgery in 5 (1.4%), pulmonic valve surgery
n 1 (0.3%), and combined CABG and valve procedures in
6 (21.7%). By univariate analysis, surgical factors predictive
f POAF were mitral valve procedures (OR: 2.42; 95% CI:
.43 to 4.15; p  0.001) and combined CABG and valve
rocedures (OR: 2.57; 95% CI: 1.47 to 4.49; p  0.001).
here was a trend toward higher rates of POAF in patients
ho had multivalvular surgery (OR: 8.31; 95% CI: 0.91 to
6.2; p  0.06). No other surgical variable was shown to be
ignificantly associated with POAF.
The rate of POAF differed according to the complexity of
he surgical procedure performed (Fig. 1). Although the
f LV Filling PressureEstimation of LV Filling Pressure
de 1
Relaxation)
Grade 2
(Pseudonormal)
Grade 3
(Reversible/Fixed Restrictive)
DT240 ms E/A 0.75–1.5, DT 160–240 ms E/A1.5, DT160 ms
E/A 0.5 E/A 0.5/0.5
8 8
E/e’ 9–12 E/e’13
r Adur S D, or ARdur-Adur30 ms S D, or ARdur-Adur30 ms
34 ml/m2 34 ml/m2
22 222
11 111
in atrial reversal flow duration; D  pulmonary vein diastolic forward flow; DT  mitral E-wavetion oand
Gra
aired
0.75,
0.5
8
, ARdu
ml/m2
al to2
al to1
nary ve
city; LA  left atrial; LV  left ventricular; S  pulmonary vein systolic forward flow; TDI  tissue
confide
a lation; P
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Pathophysiological Mechanism of POAF August 23, 2011:953–61incidence of POAF in the isolated CABG group (52 of 160
[32.5%]) and in the single-valve group (37 of 110 [33.6%])
did not differ significantly (p  0.85), patients who under-
went more complex procedures, such as combined CABG
Baseline Characteristics of the Study Population According to theTable 2 Baseline Characteristics of the Study Population Acco
Characteristic No POAF (n  216)
Age (yrs) 63.1 14.1
Men 149 (69.0)
Body surface area (m2) 1.94 0.23
Body mass index (kg/m2) 28.5 5.0
Heart rate (beats/min) 69.2 12.9
Systolic blood pressure (mm Hg) 130.5 24.5
Pulse pressure (mm Hg) 63.3 22.3
MAP (mm Hg) 90.7 13.2
Hypertension 153 (70.8)
Diabetes mellitus 57 (26.4)
Dyslipidemia 147 (68.1)
Peripheral vascular disease 32 (14.8)
Previous myocardial infarction 40 (18.5)
Creatinine 1.5 mg/dl 19 (8.8)
Smoking 143 (66.2)
Chronic lung disease 35 (16.2)
Pre-operative medication
Beta-blocker 136 (63.0)
Calcium channel blocker 45 (20.8)
Antiarrhythmic agent 1 (0.5)
ACE inhibitor 90 (41.7)
Angiotensin-receptor blocker 18 (8.3)
Diuretics 73 (33.8)
Thyroxin 27 (12.5)
Statin 114 (52.8)
Digoxin 6 (2.8)
Aspirin 165 (76.4)
Angiographic data (n  323)
Diseased vessels 1.73 1.2
LM stenosis 50% 33 (17.2)
LAD stenosis 70% 111 (57.8)
LCx stenosis 70% 81 (42.2)
RCA stenosis 70% 99 (51.6)
Values are n (%) or mean  SD.
ACE  angiotensin-converting enzyme; BMI  body mass index; BSA  body surface area; CI 
rterial pressure; MI  myocardial infarction; OR  odds ratio; POAF  post-operative atrial fibril
Univariable Surgical Predictors of POAFTable 3 Univariable Surgical Predictors of POAF
Procedure No POAF (n  216) PO
Isolated CABG 108 (50.0)
Mitral valve procedures 31 (14.5)
Aortic valve procedures 77 (35.7)
Isolated single valves 73 (33.8)
Isolated multiple valves 1 (0.5)
Combined CABG and valve 34 (15.7)
Perfusion time (min) 77.3 44.8
Cross-clamp time (min) 50.3 27.5
IABP intraoperatively 11 (5.1)
Ventilation time (h) 17.69 41.8 3Values are n (%) or mean  SD.
CABG  coronary artery bypass graft surgery; IABP  intra-aortic balloon pump; other abbreviations aand valvular surgery (42 of 76 [55.3%]) and isolated
multiple-valve surgery (4 of 5 [80.0%]), had significantly
higher rates of POAF compared with those who underwent
isolated CABG (p  0.001 and p  0.03, respectively).
rrence of New-Onset POAFto the Occurrence of New-Onset POAF
(n  135) OR 95% CI p Value
.5 10.3 1.06 1.04–1.08 0.001
7 (64.4) 0.80 0.51–1.27 0.35
6 0.25 1.28 0.51–3.22 0.60
.3 5.4 1.03 0.99–1.07 0.20
.1 12.8 1.00 0.98–1.02 0.93
.3 25.2 1.00 0.99–1.01 0.90
.4 20.8 1.01 0.99–1.02 0.20
.0 15.8 0.99 0.98–1.01 0.27
7 (79.3) 1.57 0.95–2.65 0.08
4 (25.2) 0.96 0.58–1.57 0.86
1 (74.8) 1.38 0.85–2.24 0.19
5 (18.5) 1.31 0.73–2.31 0.37
8 (20.7) 1.13 0.66–1.95 0.65
2 (16.3) 2.02 1.05–3.92 0.04
4 (62.2) 0.85 0.54–1.33 0.47
3 (17.0) 1.09 0.61–1.95 0.76
9 (65.9) 1.14 0.72–1.79 0.57
9 (21.5) 1.04 0.60–1.75 0.88
2 (1.5) 3.23 0.31–69.90 0.32
2 (45.9) 1.19 0.77–1.83 0.43
7 (12.6) 1.60 0.79–3.24 0.18
4 (40.0) 1.31 0.84–2.04 0.24
5 (11.1) 0.88 0.44–1.69 0.69
6 (56.3) 1.14 0.74–1.76 0.55
6 (4.4) 1.63 0.50–5.31 0.41
7 (79.3) 1.18 0.70–2.01 0.53
7 1.2 0.98 0.72–1.35 0.31
0 (15.3) 0.65 0.23–2.05 0.65
9 (52.7) 0.92 0.35–1.28 0.36
6 (42.7) 0.56 0.28–1.10 0.92
0 (45.8) 0.90 0.48–1.71 0.31
nce interval; LAD  left anterior descending; LCx  left circumflex; LM  left main; MAP mean
VD peripheral vascular disease; RCA  right coronary artery.
 135) OR 95% CI p Value
8.5) 0.73 0.47–1.12 0.15
8.9) 2.42 1.43–4.15 0.001
7.8) 1.10 0.70–1.71 0.68
7.4) 1.07 0.64–1.79 0.81
.0) 8.31 0.91–76.2 0.06
1.1) 2.57 1.47–4.49 0.001
 37.8 1.00 1.00–1.01 0.15
 27.7 1.01 1.00–1.02 0.08
.7) 1.32 0.53–3.29 0.54
 67.0 1.00 1.00–1.01 0.06Occurding
POAF
72
8
1.9
29
69
133
66
89
10
3
10
2
2
2
8
2
8
2
6
1
5
1
7
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1.5
2
6
5
6AF (n
52 (3
39 (2
51 (3
37 (2
4 (3
42 (3
84.1
55.8
9 (6
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POAF. Pre-operative echocardiographic hemodynamic
arameters are listed in Table 4. There was an exponential
ncrease in the rate of POAF across diastolic function grades
DFGs) (Fig. 2). Overall, the rate of POAF increased
ignificantly across DFGs (unadjusted): grade 1 versus 0,
0.001; grade 2 versus 0,0.001; grade 3 versus 0,0.001.
Only 5.1% (4 of 79) of patients with normal LV diastolic
function (grade 0) had POAF compared with 34.6% (36 of
104) who had grade 1 LV diastolic dysfunction, 58.2% (78
of 134) with grade 2 LV diastolic dysfunction, and 70.8%
(17 of 24) with grade 3 LV diastolic dysfunction (p 
0.001). However, patients younger than age 60 years with
lower grades of LV diastolic dysfunction (grades 2) were
a lower-risk group (15% risk of developing POAF). A
small proportion of the total population (n  55 [15.7%])
Figure 1 Incidence of POAF According
to Surgical Procedure Performed
The incidence of post-operative atrial fibrillation (POAF) increased
significantly according to the complexity of the surgical procedure performed.
Univariable Echocardiographic Predictors of POAFTable 4 Univariable Echocardiographic Predictors of POAF
Factor No POAF (n  216)
Diastolic function grade 0 75 (34.7)
Diastolic function grade 1 68 (31.5)
Diastolic function grade 2 66 (30.6)
Diastolic function grade 3 7 (3.2)
e’ (cm/s) 6.5 2.22
E/e’ 14.4 7.8
E/A 1.17 0.62
Mitral E-wave DT (ms) 218.0 49
PV peak systolic velocity (cm/s) 0.57 0.17
PV peak diastolic velocity (cm/s) 0.48 0.17
PVaR velocity (cm/s) 0.31 0.22
LAVI (ml/m2) 34.2 12.8
LAVI 34 ml/m2 78 (41.3)
LV mass index (g/m2) 115.9 37.8
LVEF (%) 55.4 13.2
Mitral regurgitation (moderate) 30 (13.9)Values are n (%) or mean  SD.
LAVI  left atrial volume index; LVEF  left ventricular ejection fraction; other abbreviations as in Tablhad moderate or more severe mitral regurgitation. Among
patients who had LV end-diastolic pressure measured inva-
sively (n  216), DFG was significantly correlated with LV
end-diastolic pressure (r  0.62; p  0.001), even in the
presence of mitral regurgitation.
According to univariate analysis, patients with abnormal
DFG were more likely than those with normal DFG to
have new-onset POAF (grade 1, OR: 9.9; 95% CI: 3.41 to
29.8; p  0.001; grade 2, OR: 22.2; 95% CI: 7.69 to 63.8;
p  0.001; and grade 3, OR: 45.5; 95% CI: 12.0 to 173.0;
p  0.001). Patients who developed POAF had a signifi-
cantly higher E/e’ ratio (17.3  8.2 vs. 14.4  7.8; p 
.005) and left atrial volume index (42.5  15.0 ml/m2 vs.
4.2  12.8 ml/m2; p  0.001) compared with those who
did not. An E/e’ of10 was associated with a 4-fold higher
risk of POAF (OR: 4.01; 95% CI: 1.84 to 10.3; p  0.001),
(n  135) OR 95% CI p Value
(3.0) 1.0  
(26.7) 9.9 3.41–29.8 0.001
(57.8) 22.2 7.69–63.8 0.001
(12.6) 45.5 12.00–173.0 0.001
.9 1.7 0.87 0.76–0.99 0.03
.3 8.2 1.04 1.01–1.08 0.005
5 0.74 1.21 0.88–1.68 0.24
.3 56 1.00 0.99–1.00 0.64
8 0.16 1.65 0.38–7.12 0.50
1 0.20 2.87 0.77–10.8 0.11
0 0.06 0.88 0.12–3.69 0.85
.5 15.0 1.04 1.03–1.06 0.001
(70.3) 3.36 2.08–5.51 0.001
.2 39.2 1.00 0.99–1.01 0.17
.1 13.7 1.00 0.99–1.02 0.60
(21.5) 1.69 0.96–2.96 0.07
Figure 2 Incidence of POAF as a
Function of Age and Diastolic Function
The rate of post-operative atrial fibrillation (POAF) increased significantly across
diastolic function grades (stratified by age). Grade 1 versus 0, p  0.006;
grade 2 versus 0, 0.001; grade 3 versus 0, 0.001.POAF
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Pathophysiological Mechanism of POAF August 23, 2011:953–61with a sensitivity of 93% and a specificity of 23%. A left
atrial volume index of 34 ml/m2 was associated with a
-fold higher risk of POAF (OR: 3.36; 95% CI: 2.08 to
.51; p  0.001), with a sensitivity of 70% and a specificity
f 59%. The optimal diastolic grade cut-point to identify
atients with POAF was DFG 2 (sensitivity 70.3%; speci-
city 67.0%). The area under the receiver operating char-
cteristic curve was 0.734.
ultivariate logistic regression model for predicting
ew-onset POAF. In multivariate logistic regression anal-
sis (Table 5), after adjusting for surgical and clinical risk
actors, including more than moderate mitral regurgitation,
he independent predictors of new-onset POAF were older
ge (OR: 1.05; 95% CI: 1.02 to 1.08; p  0.001), higher
ody mass index (OR: 1.06; 95% CI: 1.01 to 1.11; p 
.03), and LV diastolic dysfunction. Grade 1 diastolic
ysfunction (impaired relaxation) had an OR of 5.12 (95%
I: 1.60 to 16.38; p  0.006), grade 2 diastolic dysfunction
pseudonormal) had an OR of 9.87 (95% CI: 3.23 to 30.13;
 0.001), and grade 3 diastolic dysfunction reversible or
xed restrictive) had an OR of 28.52 (95% CI: 7.11 to
14.44; p  0.001) for predicting the risk of developing
POAF when compared with normal diastolic function
(grade 0). No procedure-related variables independently
predicted POAF. The C statistic was calculated and in-
cluded the independent predictors of POAF from the
logistic regression analysis. The area under the receiver
operating characteristic curve for the multivariate prediction
model was 0.78, confirming the predictive power of the
regression analysis.
In a subanalysis, we assessed the usefulness of left atrial
volume index with and without DFG included in the
model. In the absence of DFG, left atrial volume index was
an independent predictor of POAF (OR: 1.04; 95% CI:
1.01 to 1.06; p  0.002). However, this relationship was
attenuated after adjustment for pre-operative grade of LV
diastolic dysfunction (OR: 1.02; 95% CI: 1.00 to 1.05; p 
0.07). The addition of left atrial volume index did not affect
Multivariate Logistic Regression Model forPred cting New-Onset POAF After Cardiac SurgeryTable 5 Multivariate Logis ic Regression Model forPredicting New-Onset POAF After Cardiac Surgery
Covariates OR 95% CI p Value
Age (yrs) 1.05 1.02–1.08 0.001
BMI (kg/m2) 1.06 1.01–1.11 0.03
Hypertension 1.03 0.55–1.95 0.92
Mitral regurgitation (moderate) 1.85 0.83–4.12 0.13
Diastolic function grade 1 5.12 1.60–16.38 0.006
Diastolic function grade 2 9.87 3.23–30.13 0.001
Diastolic function grade 3 28.52 7.11–114.44 0.001
Univalvular surgery 0.90 0.46–1.73 0.75
Multivalvular surgery 4.49 0.46–43.60 0.20
CABG  valvular surgery 1.42 0.69–2.91 0.34
Perfusion time 1.00 0.99–1.01 0.89
n 351; chi-square test 102.09; area under the receiver operating characteristic curve 0.78.
BMI  body mass index; other abbreviations as in Tables 2 and 3.the predictive power of DFG to estimate the risk of POAF.Figure 3 displays the results of the incremental models for
the prediction of new-onset POAF. The C statistic was
calculated to evaluate the incremental value of left atrial
volume index and diastolic dysfunction for the prediction of
POAF above surgical and clinical risk factors alone and
combined. The C statistic increased from 0.60 and 0.73 for
surgical and clinical risk factors alone, respectively, to 0.74
for combined clinical and surgical risk factors. When left
atrial volume index was added, the C statistics increased
from 0.74 to 0.76, whereas the addition of diastolic dys-
function improved prediction of POAF from 0.74 to 0.78.
The addition of both diastolic dysfunction and left atrial
volume index improved the model even further by increas-
ing the C statistic value from 0.74 to 0.80.
Impact of POAF on clinical outcomes. During the 30-
day follow-up, post-operative complications, including
acute renal failure, new-onset renal failure requiring hemo-
dialysis, stroke, and death, were more common in patients
with POAF (n  28 [21%]) compared with those without
POAF (n  18 [9.7%]) (p  0.006). Patients with POAF
had significantly higher rates of post-operative acute renal
failure (creatinine 1.5 mg/dl) (8.9% vs. 1.9%; p  0.002)
and new-onset renal failure requiring hemodialysis (5.9% vs.
0.9%; p  0.006) compared with those without POAF.
Patients with POAF had a correspondingly longer duration
of hospitalization than patients without POAF (median 8
vs. 6 days; IQR: 6 to 11 days vs. 5 to 8 days; p 0.001). The
rate of new stroke and 30-day mortality did not differ
between the 2 groups (1.9% vs. 3.0%; p  0.50) and 8
(3.7%) versus 4 (3.0%) (p  0.71), respectively.
Discussion
Main findings. This study is, to our knowledge, the first
report to demonstrate that patients with LV diastolic
dysfunction are a population at high risk for the develop-
Figure 3 Model C Statistics
Bar graph illustrating the incremental predictive value of 6 different models for
the development of new-onset post-operative atrial fibrillation (POAF). A model
including the addition of diastolic dysfunction to surgical and clinical risk fac-
tors and left atrial volume index yielded the best prediction of new-onset POAF.
C statistic value improved from 0.74 to 0.80.
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diastolic dysfunction was a powerful independent predictor
of POAF. The rate of POAF increased exponentially across
LV DFGs. This finding may help clinicians stratify patients
undergoing cardiac surgery for risk of POAF and may be
used to plan preventive strategies for selected high-risk
individuals. Our data indicate that elevated LV filling
pressure due to abnormal LV diastolic function is a potential
physiological substrate for the initiation of POAF. This
study, therefore, establishes diastolic dysfunction as an
important predisposing factor for the initiation of new-
onset POAF after the additional physiological stress of
cardiac surgery. Interestingly, although LA volume inde-
pendently predicted new-onset POAF in the absence of
DFG, this relationship was attenuated on adjustment for
DFG without affecting the predictive power of DFG to
estimate the risk of POAF. This finding suggests that in the
absence of diastolic function assessment, LA volume, which
reflects the cumulative effects of LV filling pressures over
time, may be an acceptable surrogate of POAF risk assess-
ment. Our study was performed in a large, community-
based population of patients with and without impaired
ejection fraction, which adds statistical strength and gener-
alizability to this observation. Pre-operative, noninvasive
diastolic function assessment allows patients to be stratified
regarding the risk of POAF development and gives credence
to pre-operative management of LV filling pressure as a
potential method of reducing risk of POAF.
Incidence and clinical course of POAF. In this report,
the estimated incidence of POAF was 38.5%, which is in
accordance with the literature (4,6,9). The incidence of
new-onset POAF peaked at a median of 2 days (range 0 to
28 days) after cardiac surgery, which corresponded to time
to peak inflammation and volume overload due to mobiliza-
tion of fluid that has “third-spaced” post-operatively (19,20).
POAF lasted a median of 2 days (range 0.04 to 18 days) and
extended the patients’ duration of hospitalization by an average
of 2 days, suggesting that POAF may be an influential
contributor to increased hospital costs in patients undergoing
cardiac surgery. In keeping with results of previous reports
(6,9), complex cardiac surgical procedures were associated with
a higher frequency of POAF. This finding suggests that the
complexity of the surgical procedure may amplify the risk
associated with cardiac surgery itself; changes mediated by
stress on the atria in the context of impaired LV compliance
can increase vulnerability to development of POAF.
Comparison with previous studies. Several prior studies
have analyzed predictors of POAF. However, many were
subject to referral bias (1,4–6), included patients with a
history of AF (3–5), or confined their analysis to patients
undergoing isolated CABG surgery (1,18,21), which lim-
ited a wider extrapolation of their findings. The risk factors
identified in our population-based series predict the occur-
rence of POAF more accurately than those derived from
more highly selected patient groups. Advanced age has been
the only consistent, yet immutable, independent predictorof POAF (3,5,9,21). This finding is probably due to the
high frequency of age-related structural changes such as
degeneration of large-vessel elastin, increase in afterload,
altered filling dynamics, atrial dilation, fibrosis, and electri-
cal heterogeneity (10–12,22).
In keeping with results of prior studies (1,4,18), the
occurrence of POAF was significantly associated with other
post-operative complications. Diastolic dysfunction was
likely a predisposing common denominator underlying
these endpoints. Indeed, similar to the study of Albahrani et
al. (20), our study reported a significant difference in the
incidence of new-onset acute renal dysfunction and renal
dysfunction requiring dialysis in patients with POAF, sug-
gesting that volume overload, in the background of impaired
diastolic distensibility, likely elevates atrial pressure and
potentiates the development of POAF.
Pathophysiological mechanism of new-onset POAF: role
of diastolic dysfunction. Aging is associated with an
increase in fibrosis (22,23), which results in progressive
remodeling and increased stiffness of the atrial and ventric-
ular myocardium. Atrial interstitial fibrosis increases with
age in animal models and in humans; it has been observed
particularly in patients with AF (24–26). This increase in
atrial fibrosis corresponds to an increase in conduction
heterogeneity and AF vulnerability (27,28). Through these
studies, it has been shown that atrial fibrosis and impaired
LV compliance, especially when superimposed by the acute
stress of surgical intervention (29), create a profibrillatory
environment that is manifested clinically as POAF.
Diastolic dysfunction is associated with an increasing
stretch in pulmonary veins due to increased left atrial
pressure (30). As previously reported by Chang et al. (31),
the stretch-induced increase in the arrhythmogenic activity
of the pulmonary veins due to impaired diastolic distensi-
bility, as extrapolated from the present study, may have an
important role in the pathophysiology of POAF.
Clinical implications. To date, prophylactic therapies for
POAF are largely empirical. We have identified a patho-
physiological mechanism underlying the development of
POAF, which may provide a target for development of
novel preventive therapies. The present study suggests that
a pre-existing condition (e.g., reduced LV compliance) and
a trigger (e.g., cardiac surgery) are necessary for the devel-
opment of POAF. We have shown that irrespective of age,
the more severe the DFG, the higher the risk of POAF.
This finding suggests that POAF may be preventable by
optimizing pre-operative management of LV filling hemo-
dynamics, particularly for patients with DFG 2 or higher.
Pre-operative 2-dimensional and Doppler echocardiog-
raphy findings showing impairment of diastolic filling
should be investigated. Specifically tailored strategies that
aim to decrease LV diastolic filling pressure pre-operatively
may be a potential strategy of prophylaxis against POAF in
high-risk patients undergoing cardiac surgery. Our findings
suggest that aggressive preventative measures should be
applied to high-risk patients undergoing cardiac surgery. In
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dysfunction pre-operatively to influence the risk of POAF
in the short term is currently not possible. Therefore, a more
practical approach might be to target individuals at the
highest risk (grade 2 diastolic dysfunction) for prophylaxis
with antifibrillatory therapy before cardiac surgery.
Study strengths and limitations. The major strengths of
this study are its large, population-based cohort of patients
that included men and women from a broad age range and
the detailed, prospective collection of data that included
information about numerous potential confounders. Knowl-
edge of independent physiological predictors for POAF and
associated complications may more accurately define risk
and aggressively optimize pre-operative physiology.
There are several limitations to the interpretation of our
data. In the present study, a small proportion of the total
population had clinically significant mitral regurgitation,
which potentially could have affected results. However,
among patients who had LV end-diastolic pressure mea-
sured invasively, DFG was significantly correlated with LV
end-diastolic pressure, even in the presence of mitral regur-
gitation. Additionally, when patients with significant mitral
regurgitation were excluded from the analysis, results did
not change. Moreover, in multivariate analysis, the impact
of mitral regurgitation on the occurrence of POAF was
insignificant.
Our study investigated AF that occurred within 30 days
after surgery. POAF cases, especially those with paroxysmal
AF, likely were missed if they occurred outside of the
hospital setting. As a result, we may have underestimated
the incidence of POAF, which should bias the results in
favor of the null hypothesis and against the significant
association between diastolic dysfunction and new-onset
POAF in this study. However, we studied a unique,
community-based sample, drawn from a local population
that receives most of its medical care at the Mayo Clinic. All
patients were surveyed and all clinically available means
were used to capture all occurrences of POAF. In addition,
our findings were consistent with those of many studies and
showed that most POAF episodes occurred in the first 3
days after cardiac surgery (1,5). Another limitation of this
study is the lack of specific data for systemic inflammation,
an important consideration in the post-operative state.
However, in our study, the incidence of POAF peaked on
the second post-operative day, which corresponds to time to
peak inflammation after cardiac surgery (19).
Conclusions
Diastolic dysfunction is a powerful predisposing substrate
for the initiation of POAF after cardiac surgery. Pre-
operative assessment of diastolic function allows identifica-
tion of high-risk patients who might benefit from prophy-
lactic treatment and may provide useful prognostic
information for individual patients. Further studies are
needed to show whether reduction of LV filling pressurebefore cardiac surgery is correlated with a consequent
reduction in the risk of POAF.
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